| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $350K | -27.6% |
| R&D Expense | $21.4M | +28.9% |
| SG&A Expense | $8.6M | -4.0% |
| Operating Income | -$29.7M | -18.3% |
| Net Income | -$29.7M | -19.0% |
| EPS (Basic) | -$6.84 | +52.0% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Current Assets | $5.4M | -81.2% |
| Total Assets | $5.8M | -79.9% |
| Current Liabilities | $8.2M | +21.8% |
| Total Liabilities | $8.4M | +24.3% |
| Stockholders' Equity | -$2.5M | -111.4% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.7M | -22.8% |
| Capital Expenditures | $4K | +0.0% |
| Investing Cash Flow | -$896K | — |
| Financing Cash Flow | $4.0M | -90.6% |
| Free Cash Flow | -$27.7M | -22.8% |